Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy
Tzu‐Chieh Ho, Hye Sung Kim, Yumei Chen, et al.
Science Advances (2021) Vol. 7, Iss. 21
Open Access | Times Cited: 82

Showing 26-50 of 82 citing articles:

Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics
Vinayak Nayak, Sushmita Patra, Kshitij RB Singh, et al.
Environmental Research (2023) Vol. 235, pp. 116573-116573
Closed Access | Times Cited: 20
Cascade dynamic assembly/disassembly of DNA nanoframework enabling the controlled delivery of CRISPR-Cas9 system
Nachuan Song, Yiwen Chu, Shuai Li, et al.
Science Advances (2023) Vol. 9, Iss. 35
Open Access | Times Cited: 18
The Tissue Engineering Revolution: From Bench Research to Clinical Reality
Francesco De Chiara, Ainhoa Ferret-Miñana, Juan M. Fernández‐Costa, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 453-453
Open Access | Times Cited: 8
Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach
Ehsan Bitaraf Haghighi, Samira Sadat Abolmaali, Ali Dehshahri, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Nano-vectors for CRISPR/Cas9-mediated genome editing
Peng Yang, Athena Yue-Tung Lee, Jingjing Xue, et al.
Nano Today (2022) Vol. 44, pp. 101482-101482
Open Access | Times Cited: 25
Direct Cytosolic Delivery of Proteins and CRISPR-Cas9 Genome Editing by Gemini Amphiphiles via Non-Endocytic Translocation Pathways
Zhicheng Le, Qi Pan, Zepeng He, et al.
ACS Central Science (2023) Vol. 9, Iss. 7, pp. 1313-1326
Open Access | Times Cited: 15
A Dual‐Enzyme–Responsive DNA‐Based Nanoframework Enables Controlled Co‐Delivery of CRISPR‐Cas9 and Antisense Oligodeoxynucleotide for Synergistic Gene Therapy
Nachuan Song, Yiwen Chu, Shuai Li, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 47
Closed Access | Times Cited: 15
Biomaterial-Based CRISPR/Cas9 Delivery Systems for Tumor Treatment
Mengmeng Li, Fenglei Chen, Qian Yang, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 6
Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia
Xia Wu, Fangfang Wang, Xijing Yang, et al.
Small (2024) Vol. 20, Iss. 42
Closed Access | Times Cited: 5
Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges
Lei Xu, Yuan Cao, XU Ya, et al.
Macromolecular Bioscience (2023) Vol. 24, Iss. 3
Closed Access | Times Cited: 12
The Current Situation and Development Prospect of Whole-Genome Screening
Caiting Yang, Lei Yu, Tinglin Ren, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 658-658
Open Access | Times Cited: 4
CRISPR-Cas9 in basic and translational aspects of cancer therapy
Maryam Samareh Salavatipour, Zahra Poursalehi, Negin Hosseini Rouzbahani, et al.
Bioimpacts (2024) Vol. 14, Iss. 6, pp. 30087-30087
Open Access | Times Cited: 4
Current landscape of mRNA technologies and delivery systems for new modality therapeutics
Ruei‐Min Lu, Hsiang-En Hsu, Ser John Lynon P Perez, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 4
CRISPR/Cas9 for hepatitis B virus infection treatment
Bo Cai, Shixue Chang, Yuhan Tian, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 10
Soybean Oil‐Derived Lipids for Efficient mRNA Delivery
Zhongmin Tang, Fan Yu, Jessica C. Hsu, et al.
Advanced Materials (2023) Vol. 36, Iss. 13
Open Access | Times Cited: 10
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics
Nicole Santoro, Prassede Salutari, Mauro Di Ianni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4259-4259
Open Access | Times Cited: 3
Non-Invasive Delivery of CRISPR/Cas9 Ribonucleoproteins (Cas9 RNPs) into Cells via Nanoparticles for Membrane Transport
Toshihiko Tashima
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 201-201
Open Access
Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets
Rebecca M. Haley, Marshall S. Padilla, Rakan El‐Mayta, et al.
ACS Nano (2025)
Closed Access
Biomimetic nanofibers with cell membrane functionalization for enhanced tissue engineering
Xinyuan Jiang, Zhu Yuling, Peixing Chen, et al.
Biomaterials Science (2025)
Closed Access
Dendritic cell-mimicking scaffolds for ex vivo T cell expansion
Hye Sung Kim, Tzu‐Chieh Ho, Moshe J. Willner, et al.
Bioactive Materials (2022) Vol. 21, pp. 241-252
Open Access | Times Cited: 16
CRISPR medicine for blood disorders: Progress and challenges in delivery
Tahereh Mohammadian, Guillermo Ureña-Bailén, Yujuan Hou, et al.
Frontiers in Genome Editing (2023) Vol. 4
Open Access | Times Cited: 9
Adeno-Associated Virus-Mediated Gene Therapy
Hassan Zaman, Aakif Ullah Khan, Khalid Mohammed Khan, et al.
Critical Reviews in Eukaryotic Gene Expression (2023) Vol. 33, Iss. 6, pp. 87-100
Closed Access | Times Cited: 9
Biomembrane-wrapped gene delivery nanoparticles for cancer therapy
Jie Li, Huamin Zeng, Luwei Li, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 9
microRNA expression in acute myeloid leukaemia: New targets for therapy?
Daniel Fletcher, Elliott Brown, Julliah Javadala, et al.
eJHaem (2022) Vol. 3, Iss. 3, pp. 596-608
Open Access | Times Cited: 13
3D bioprinting of gene delivery scaffolds with controlled release
Yi Xiang, Zheng Zhong, Emmie Yao, et al.
Bioprinting (2023) Vol. 31, pp. e00270-e00270
Open Access | Times Cited: 7

Scroll to top